UNSPSC 51282952: Decoquinate

This classification denotes a quinolone antibiotic with the molecular formula C24H35NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 534I52PVWH, chemically known as 3-quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester but more generally known as decoquinate, which bears US NIH Compound Identifier 29112. European Medicines Agency schedules Decoquinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06938MIG.

The term DECOQUINATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 23, No. 10 1969, List 9). DECOQUINATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(CCCCCCCCCC)C1C(OCC)CC2[NH]CC(C(=O)C2C1)C(=O)OCC.

UNSPSC 51282952 Decoquinate is a Commodity code for a specific anticocccidial feed additive used in animal agriculture, though recent state and local procurement activity under this code does not reflect purchases of decoquinate itself. Instead, the code appears in the state and local opportunity record as a tagging artifact; the two recent opportunities named in the dataset involve pharmaceutical products for human use — antibiotics (doxycycline and ciprofloxacin) supplied through a cooperative purchasing warehouse contract, and naloxone plus drug deactivation systems for community health — neither of which aligns with the code's stated commodity scope. State and local procurement offices occasionally mislabel opportunities during intake, and this code shows a mismatch between its taxonomy definition and the actual work being bought in the field right now.

The Illinois Department of Public Health and Seminole County, Florida are the issuing bodies represented in the recent record. The Illinois opportunity, posted August 28, 2026, was a completed piggyback pharmaceutical warehouse award through the MMCAP Infuse consortium to Chartwell Rx LLC for antibiotic tablets totaling $2.999 million over a 12-month initial term plus two renewal years; Seminole County's June 30, 2026 IFB sought annual supplies of naloxone (1,900 units) and safe drug deactivation systems (800 units) with quarterly deliveries. Given the code-to-opportunity mismatch, decoquinate does not appear to be a meaningful procurement category for state and local governments in the current market, and firms should verify the actual commodity code before pursuing work tagged under 51282952.